A recent study published in the BMJ evaluated the effects of long-term exposure to low-dose ionizing radiation on cancer mortality. Study: Cancer mortality after low dose exposure to ionising ...
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results